Abu Ferdous

Abu Ferdous has extensive experience in the pharmaceutical industry, specializing in drug formulation and development. Abu is currently serving as the Director of Drug Product Development & Manufacturing at Repare Therapeutics since July 2021. Prior to this, they worked as an Independent Consultant and held the position of Director of Formulation Development at ORIC Pharmaceuticals Inc. from October 2020 to April 2021. From September 2018 to October 2020, Abu was the Sr. Principal Scientist/Head of Formulation Development at Corbus Pharmaceuticals. Abu also worked as an Independent Consultant in Pharmaceutical Development, Executive Director of Pharmaceutical Development at Applied Molecular Transport, and Director of Formulation at Principia Biopharma. Abu has held various senior-level positions in formulation and product development at UPM Pharmaceuticals, Takeda/Millennium Pharmaceuticals, and UCB Pharma/Celltech throughout their career.

Abu Ferdous's education history indicates that they pursued a PhD in Pharmaceutics from the University of Manchester in the UK. No additional information is available regarding the specific duration of their studies or any previous educational experiences.